Pharmaceuticals - Community Register


Community list of not active veterinary medicinal products


Product information

Invented name: ProMeris
Auth. number : EU/2/06/064
Active substance : Metaflumizone
ATC: Anatomical main group: QP - Antiparasitic products, insecticides and repellents
Therapeutic subgroup: QP53 - Ectoparaciticides, insecticides and repellents
Pharmacological subgroup: QP53A - Ectoparasiticides for topical use, incl. insecticides
Chemical subgroup: QP53AX - Other ectoparasiticides for topical use
Chemical substance: QP53AX25 - prulifloxacin
(See WHO ATCvet Index)
Indication: Treatment and prevention of flea infestations (Ctenocephalides canis and C. felis) in cats. The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
Marketing Authorisation Holder: Pfizer Limited
Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/12/2006 Centralised - Authorisation EMEA/V/C/107 (2006)7089 of 19/12/2006
03/05/2007 Centralised - Variation EMEA/V/C/107/IB/1
Updated with Decision(2008)7 of 03/01/2008
11/12/2007 Centralised - Variation EMEA/V/C/107/IB/2
Updated with Decision(2008)3701 of 11/07/2008
07/01/2008 Centralised - Variation (2008)7 of 03/01/2008
15/07/2008 Centralised - Variation (2008)3701 of 11/07/2008
08/04/2009 Centralised - Variation EMEA/V/C/107/IB/3
Updated with Decision(2009)5129 of 22/06/2009
25/06/2009 Centralised - Variation EMEA/V/C/107/II/4 (2009)5129 of 22/06/2009
07/12/2009 Centralised - Variation (no change in Commission Decision) EMEA/V/C/107/IB/5
08/12/2009 Centralised - Variation (no change in Commission Decision) EMEA/V/C/107/IB/6
15/10/2010 Centralised - Variation (no change in Commission Decision) EMEA/V/C/107/IB/7
03/12/2010 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/107/T/8 (2010)8552 of 26/11/2010
03/01/2011 Centralised - Variation EMEA/V/C/107/IB/9
Updated with Decision(2011)5588 of 27/07/2011
01/08/2011 Centralised - Variation (2011)5588 of 27/07/2011
15/11/2011 Centralised - Renewal EMEA/V/C/107/R/10 (2011)8241 of 10/11/2011
06/01/2012 Centralised - Variation EMEA/V/C/107/IB/12
Updated with Decision(2012)5294 of 20/07/2012
25/07/2012 Centralised - Variation (2012)5294 of 20/07/2012
10/07/2015 Centralised - Withdrawal (2015)4860 of 08/07/2015